These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6765520)

  • 41. Immunoglobulin G-insulin antibodies and immune region-associated alloantigens in insulin-dependent diabetes mellitus.
    Schernthaner G; Ludwig H; Mayr WR
    J Clin Endocrinol Metab; 1979 Mar; 48(3):403-7. PubMed ID: 429493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can insulin antibodies of diabetic patients distinguish human insulin from porcine insulin?
    Ishibashi O; Kobayashi M; Maegawa H; Watanabe N; Takata Y; Okuno Y; Shigeta Y
    Horm Metab Res; 1986 Jul; 18(7):470-2. PubMed ID: 2427427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin.
    Luyckx AS; Daubresse JC; Jaminet C; Scheen A; Lefebvre PJ
    Acta Diabetol Lat; 1986; 23(2):101-6. PubMed ID: 3529776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intractable diabetic ketoacidosis due to insulin antibody--response to steroid therapy.
    Chang TC; Jap TS; Kwok CF; Won JG; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Feb; 45(2):83-6. PubMed ID: 2168254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigenicity of "monocomponent" pork insulin in diabetic subjects.
    Yue DK; Turtle JR
    Diabetes; 1975 Jul; 24(7):625-32. PubMed ID: 1171804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity of highly purified porcine and human insulins in diabetic patients with high titers of insulin antibody.
    Lam HC; Ho LT; Tang KT; Wang LM; Kwok CF; Liu YF; Hsiao LJ; Li SH
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):346-51. PubMed ID: 2677227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity of biosynthetic human LysPro insulin compared to native-sequence human and purified porcine insulins in rhesus monkeys immunized over a 6-week period.
    Zwickl CM; Smith HW; Zimmermann JL; Wierda D
    Arzneimittelforschung; 1995 Apr; 45(4):524-8. PubMed ID: 7779155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin antibodies in 104 children with diabetes mellitus.
    Nars PW; Herz G; Girard J
    Eur J Pediatr; 1976 Jun; 122(3):217-22. PubMed ID: 1278189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with insulin-dependent diabetes mellitus and generation of high affinity human monoclonal IgG to insulin.
    Casali P; Nakamura M; Ginsberg-Fellner F; Notkins AL
    J Immunol; 1990 May; 144(10):3741-7. PubMed ID: 2159034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin.
    Oak S; Phan TH; Gilliam LK; Hirsch IB; Hampe CS
    Acta Diabetol; 2010 Jun; 47(2):131-5. PubMed ID: 19547910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement.
    McEvoy RC; Witt ME; Ginsberg-Fellner F; Rubinstein P
    Diabetes; 1986 Jun; 35(6):634-41. PubMed ID: 3519320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatment.
    Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W
    Horm Metab Res; 1982 May; 14(5):227-32. PubMed ID: 7047344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advantages and drawbacks of human insulin].
    Zenobi PD
    Schweiz Med Wochenschr; 1991 Apr; 121(14):475-81. PubMed ID: 2035004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Presence of insulin autoantibodies as regular feature of nondiabetic repertoire of immunity.
    Fineberg SE; Biegel AA; Durr KL; Hufferd S; Fineberg NS; Anderson JH
    Diabetes; 1991 Sep; 40(9):1187-93. PubMed ID: 1936623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?
    Kim MR; Sheeler LR; Mansharamani N; Haug MT; Faiman C; Gupta MK
    Endocrine; 1997 Jun; 6(3):285-91. PubMed ID: 9368685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals.
    Naquet P; Ellis J; Tibensky D; Kenshole A; Singh B; Hodges R; Delovitch TL
    J Immunol; 1988 Apr; 140(8):2569-78. PubMed ID: 2451692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histocompatability antigens and immunoglobulin G insulin antibodies in Mexican-American insulin-dependent diabetic patients.
    Zeidler A; Frasier SD; Kumar D; Loon J
    J Clin Endocrinol Metab; 1982 Mar; 54(3):569-73. PubMed ID: 7035484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The human cellular immune response to insulin: a study in unexposed control subjects and type I diabetic patients on acute and chronic treatment.
    Richens ER; Seward ME; Luqman WA; Hartog M
    Acta Diabetol Lat; 1986; 23(4):309-22. PubMed ID: 3551427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment.
    Kuglin B; Gries FA; Kolb H
    Diabetes; 1988 Jan; 37(1):130-2. PubMed ID: 3275554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of insulin antibodies on insulin dose and diabetic control.
    Walford S; Allison SP; Reeves WG
    Diabetologia; 1982 Feb; 22(2):106-10. PubMed ID: 7037511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.